.title-desc-inner sqs-frontend-overlay-editor-widget-host { padding: none; }

Kimon Angelides, PHD

Vivante Health
Founder & CEO

Kim is the founder of four healthcare companies: Vivante, Livongo, the leading digital diabetes company, DiabetesAmerica, a network of diabetes centers that pioneered the at-risk and bundled payment models, and mAbGen, a cancer biotech company that partnered with MDAnderson Cancer Center and was acquired by Valeant Pharmaceuticals.

Kim’s newest company, Vivante Health, was created in early 2016, after he left Livongo, to tackle the needs of people who have invisible and stigmatized diseases, who have been neglected in the healthcare system. The first product, GIThrive, takes on digestive diseases which affects more than 70M Americans. Digestive trouble is something most people don’t want to discuss. It’s understandable—symptoms like diarrhea, constipation, gas and bloating are embarrassing and stigmatized and drastically impact people’s home and work lives. His goal is to destigmatize these conditions by using state of the art psychosocial, clinical, nutritional and microbiome science to improve the lives of these people and to reduce healthcare costs.

Prior to his healthcare career, Kim was the Chief Strategic Officer at Tanox, Inc which sold to Genentech (NYSE: DNA) for $1B, Director of Strategic Development at St Luke’s/Texas Heart Institute, Professor and Chair of Cell Biology and Biomedical Sciences at the University of Durham in the UK, Professor of Cell Biology, Neuroscience, Biochemistry, and Molecular Biophysics at Baylor College of Medicine, and Associate and Assistant Professor at the University of Florida and McGill University. Kim has served on the National Medical Advisory Boards of the National Multiple Sclerosis Society, Muscular Dystrophy Association, and the National Institutes of Health. Kim was Research Career Development Award from the NIH, a Mombusho Scholar of Japan, Distinguished Professor at INSERM/Centre National de Recherche Scientifique of France, and a Basil O’Connor Scholar from the March of Dimes Birth Defect Foundation. He has published over 100 papers and holds more than 40 patents. He received a PhD in Chemistry from the University of California and has done graduate study in business, laws, and public health.